Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001593968-20-001317)

Filing Details

Accession Number:: 0001593968-20-001317
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-06-02 16:35:46
Reporting Period:: 2020-06-01

Accepted Time:: 2020-06-02 16:35:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1771917	Karuna Therapeutics Inc.	KRTX	Pharmaceutical Preparations (2834)	270605902

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1777631	K. Stephen Brannan	C/O Karuna Therapeutics, Inc. 33 Arch St Ste 3110 Boston MA 02110-1424	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-06-01	2,500	$5.45	12,500	No	4	M	Direct
Common Stock	Acquisiton	2020-06-01	7,728	$7.27	20,228	No	4	M	Direct
Common Stock	Disposition	2020-06-01	7,728	$90.64	12,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Disposition	2020-06-01	2,500	$0.00	2,500	$5.45
Common Stock	Option (right to buy)	Disposition	2020-06-01	7,728	$0.00	7,728	$7.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
61,329	2018-03-01	2027-06-02	No	4	M	Direct
48,133	2019-02-08	2028-08-09	No	4	M	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.